CD38 and neoplasm: Mechanisms of resistance against CD38 antibodies can be divided into tumor intrinsic resistance mechanisms, and immune microenvironment‐related resistance mechanisms, and numerous strategies are currently being investigated to overcome these resistance mechanisms (Figure 4).